An international study which examined more than 100 thousand women with breast cancer has found that almost all forms of hormone replacement therapy are associated with an increased risk of breast cancer.
For women who have never used hormone replacements, the breast cancer rate was 6.3 per cent.
This rose to 8.3 per cent for those who had used hormone replacements for five years.
The findings reinforce previous studies which have shown a link between hormone replacement therapy and breast cancer.
-
Lêkolîneke navnetewî zêdetirî 100,000 jinên ku şêrpenceya pêsîrê bi wan re heye dîtin ku hemî cûre teropiya şûngirtina hormonê bi zêdebûna metirsiya şêrpenceya pêsîrê re têkildarin.
Jinên ku tu caran têrepiya hormonan bi kar ne înane asta şêrpenceya di pêsîran de 6.3 bû.
Lê ew kesên ku terapiya şûngirtina hormonê bo 5 salan bi kar anîne asta şêrpenceyê rabû 8.3.